PD-L1 and intratumoral immune response in breast cancer.

Oncotarget · 2017 · PMC5584276 · PMID 28881675

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Within the combined group of Triple Negative breast cancers (TNNB and Basal-like subsets), PD-L1 positive status showed a trend toward better OS and was significantly associated with RFS; in contrast, eCD8 TIL positive status was not associated with RFS or OS (data not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.